首页> 美国卫生研究院文献>Springer Open Choice >Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials

【2h】

Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials

机译：基于非AC的中度致呕性化疗后延迟化疗引起的恶心和呕吐的预防性治疗：随机对照试验的系统评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeDelayed chemotherapy-induced nausea and vomiting (CINV) remains an important adverse effect of moderately emetogenic chemotherapy not containing anthracyclines and cyclophosphamide (non-AC MEC). In this review, we summarize current literature to update recommendations for delayed CINV prophylaxis after non-AC MEC.

机译：目的延迟化疗引起的恶心和呕吐（CINV）仍然是不含蒽环类和环磷酰胺（非AC MEC）的中度致呕性化疗的重要不良反应。在这篇综述中，我们总结了当前的文献以更新非AC MEC后延迟CINV预防的建议。

著录项

期刊名称 Springer Open Choice
作者
Maurice J. D. L van der Vorst; Elisabeth C. W. Neefjes; Inge R. H. M. Konings; Henk M. W. Verheul;
展开▼
作者单位

展开▼
年(卷),期 -1(23),8
年度 -1
页码 2499–2506
总页数 8
原文格式 PDF
正文语种
中图分类外科学;
关键词
Antiemetics Delayed CINV Moderately emetogenic chemotherapy;

机译：止吐药;延迟CINV;中度致呕化疗;

相似文献

外文文献
中文文献
专利

1. Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials [J] . van der Vorst Maurice J. D. L., Neefjes Elisabeth C. W., Konings Inge R. H. M., Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2015,第8期

机译：基于非AC的中度致呕性化疗后延迟化疗引起的恶心和呕吐的预防性治疗：随机对照试验的系统评价
2. Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial [J] . Maurice J.D.L. van der Vorst, Johannes Berkhof, Henk M.W. Verheul, The oncologist . 2021,第1期

机译：用于预防延迟化疗诱导的恶心和呕吐后，甲基丙普替普胺，甲酰甲酰胺，或呕吐在中等胰腺化疗（MEDEA）：随机，期III，非血小效性试验
3. Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial [J] . Schwartzberg Lee S., Modiano Manuel R., Rapoport Bernardo L., The lancet oncology . 2015,第9期

机译：罗拉吡坦预防中度致癌的化疗或蒽环类和环磷酰胺治疗癌症患者后，预防化疗引起的恶心和呕吐的安全性和有效性：一项随机，主动控制，双盲，3期试验
4. Hollow silicon microneedle array based trans-epidermal antiemetic patch for efficient management of Chemotherapy Induced Nausea and Vomiting [C] . Bhushan N Kharbikar, Harish Kumar S, Sindhu Kr, Micro+nano materials, devices, and systems . 2015

机译：基于中空硅微针阵列的经表皮止吐贴剂可有效管理化学疗法诱发的恶心和呕吐
5. Aprepitant for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting in Children: Overcoming Barriers [D] . Patel, Priya 2018

机译：预防急性化疗引起的儿童恶心和呕吐的阿瑞品：克服障碍
6. Olanzapine combined with 5-hydroxytryptamine type 3 receptor antagonist (5-HT3 RA) plus dexamethasone for prevention and treatment of chemotherapy-induced nausea and vomiting in high and moderate emetogenic chemotherapy: a systematic review and meta-analysis of randomised controlled trials [O] . Jian-Guo Zhou, Lang Huang, Su-Han Jin, 2020

机译：奥氮平联合5-羟色胺3型受体拮抗剂（5-HT3 RA）联合地塞米松预防和治疗高中度致癌化学疗法所致的恶心和呕吐：随机对照试验的系统评价和荟萃分析
7. Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials [O] . Maurice J. D. L van der Vorst, Elisabeth C. W. Neefjes, Inge R. H. M. Konings, 2015

机译：基于非AC的中度致呕性化疗后延迟化疗引起的恶心和呕吐的预防性治疗：随机对照试验的系统评价

Prophylactic treatment for delayed chemotherapy-induced nausea and vomiting after non-AC based moderately emetogenic chemotherapy: a systematic review of randomized controlled trials

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅